Estradiol induces endothelial cell migration and proliferation through estrogen receptor-enhanced RhoA/ROCK pathway

Molecular and Cellular Endocrinology

Volumn 335, Issue 2, 2011, Pages 96-103

  Oviedo, Pilar J ^a   Sobrino, Agua ^a   Laguna Fernandez, Andrés ^a   Novella, Susana ^a,b   Tarín, Juan J ^b   García Pérez, Miguel Angel ^a   Sanchís, Juan ^a   Cano, Antonio ^b   Hermenegildo, Carlos ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Cell cycle regulators; Endothelial function; Estrogens; Migration

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; ESTRADIOL; ESTROGEN RECEPTOR; PROTEIN P27; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; CELL CYCLE; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ESTROGEN ACTIVITY; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHO GEF 1 GENE; STRESS FIBER; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

CELL CYCLE PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME ASSAYS; ESTRADIOL; FEMALE; HUMANS; MALE; RECEPTORS, ESTROGEN; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; UMBILICAL CORD; UP-REGULATION;

EID: 79951721608     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.06.020     Document Type: Article

References (45)

1. Andres V. Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling: new perspectives and therapeutic potential. Cardiovasc. Res. 2004, 63:11-21.
2. Bar-Sagi D., Hall A. Ras and Rho GTPases: a family reunion. Cell 2000, 103:227-238.
3. Buchsbaum R.J. Rho activation at a glance. J. Cell Sci. 2007, 120:1149-1152.
4. Caldon C.E., Sergio C.M., Schutte J., Boersma M.N., Sutherland R.L., Carroll J.S., Musgrove E.A. Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc. Mol. Cell. Biol. 2009, 29:4623-4639.
5. Chen J., Guerriero E., Lathrop K., SundarRaj N. Rho/ROCK signaling in regulation of corneal epithelial cell cycle progression. Invest. Ophthalmol. Vis. Sci. 2008, 49:175-183.
6. Cicatiello L., Addeo R., Sasso A., Altucci L., Petrizzi V.B., Borgo R., Cancemi M., Caporali S., Caristi S., Scafoglio C., Teti D., Bresciani F., Perillo B., Weisz A. Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/Estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter. Mol. Cell. Biol. 2004, 24:7260-7274.
7. Cid M.C., Schnaper H.W., Kleinman H.K. Estrogens and the vascular endothelium. Ann. N. Y. Acad. Sci. 2002, 966:143-157.
8. Coleman M.L., Marshall C.J., Olson M.F. RAS and RHO GTPases in G1-phase cell-cycle regulation. Nat. Rev. Mol. Cell Biol. 2004, 5:355-366.
9. Concina P., Sordello S., Barbacanne M.A., Elhage R., Pieraggi M.T., Fournial G., Plouet J., Bayard F., Arnal J.F. The mitogenic effect of 17beta-estradiol on in vitro endothelial cell proliferation and on in vivo reendothelialization are both dependent on vascular endothelial growth factor. J. Vasc. Res. 2000, 37:202-208.
10. Croft D.R., Olson M.F. The Rho GTPase effector ROCK regulates cyclin A, cyclin D1, and p27Kip1 levels by distinct mechanisms. Mol. Cell. Biol. 2006, 26:4612-4627.
11. Eeckhoute J., Carroll J.S., Geistlinger T.R., Torres-Arzayus M.I., Brown M. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes Dev. 2006, 20:2513-2526.
12. Favot L., Martin S., Keravis T., Andriantsitohaina R., Lugnier C. Involvement of cyclin-dependent pathway in the inhibitory effect of delphinidin on angiogenesis. Cardiovasc. Res. 2003, 59:479-487.
13. Filipe C., Lam Shang Leen L., Brouchet L., Billon A., Benouaich V., Fontaine V., Gourdy P., Lenfant F., Arnal J.F., Gadeau A.P., Laurell H. Estradiol accelerates endothelial healing through the retrograde commitment of uninjured endothelium. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H2822-H2830.
14. Giretti M.S., Fu X.D., De Rosa G., Sarotto I., Baldacci C., Garibaldi S., Mannella P., Biglia N., Sismondi P., Genazzani A.R., Simoncini T. Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion. PLoS ONE 2008, 3:e2238.
15. Gustafsson N., Zhao C., Gustafsson J.A., hlman-Wright K. RBCK1 drives breast cancer cell proliferation by promoting transcription of estrogen receptor α and cyclin B1. Cancer Res. 2010, 70:1265-1274.
16. Hengst L., Reed S.I. Translational control of p27Kip1 accumulation during the cell cycle. Science 1996, 271:1861-1864.
17. Hermenegildo C., Oviedo P.J., Garcia-Perez M.A., Tarin J.J., Cano A. Effects of phytoestrogens genistein and daidzein on prostacyclin production by human endothelial cells. J. Pharmacol. Exp. Ther. 2005, 315:722-728.
18. Ho P.Y., Liang Y.C., Ho Y.S., Chen C.T., Lee W.S. Inhibition of human vascular endothelial cells proliferation by terbinafine. Int. J. Cancer 2004, 111:51-59.
19. Horwitz A.R., Parsons J.T. Cell migration-Movin' on. Science 1999, 286:1102-1103.
20. Hotulainen P., Lappalainen P. Stress fibers are generated by two distinct actin assembly mechanisms in motile cells. J. Cell Biol. 2006, 173:383-394.
21. Loirand G., Guilluy C., Pacaud P. Regulation of Rho proteins by phosphorylation in the cardiovascular system. Trends Cardiovasc. Med. 2006, 16:199-204.
22. Mendelsohn M.E., Karas R.H. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 1999, 340:1801-1811.
23. Miller V.M., Mulvagh S.L. Sex steroids and endothelial function: translating basic science to clinical practice. Trends Pharmacol. Sci. 2007, 28:263-270.
24. Morales D.E., McGowan K.A., Grant D.S., Maheshwari S., Bhartiya D., Cid M.C., Kleinman H.K., Schnaper H.W. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 1995, 91:755-763.
25. O'Lone R., Knorr K., Jaffe I.Z., Schaffer M.E., Martini P.G.V., Karas R.H., Bienkowska J., Mendelsohn M.E., Hansen U. Estrogen receptors {alpha} and {beta} mediate distinct pathways of vascular gene expression including genes involved in mitochondrial electron transport and generation of reactive oxygen species. Mol. Endocrinol. 2007, 21:1281-1296.
26. Oktay M., Wary K.K., Dans M., Birge R.B., Giancotti F.G. Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle. J. Cell Biol. 1999, 145:1461-1470.
27. Oviedo P.J., Hermenegildo C., Tarin J.J., Cano A. Raloxifene increases proliferation of human endothelial cells in association with increased gene expression of cyclins A and B1. Fertil. Steril. 2007, 88:326-332.
28. Regitz-Zagrosek V. Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat. Rev. Drug Discov. 2006, 5:425-439.
29. Rikitake Y., Kim H.H., Huang Z., Seto M., Yano K., Asano T., Moskowitz M.A., Liao J.K. Inhibition of Rho Kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke 2005, 36:2251-2257.
30. Roberts J.M. Evolving ideas about cyclins. Cell 1999, 98:129-132.
31. Rolfe B.E., Worth N.F., World C.J., Campbell J.H., Campbell G.R. Rho and vascular disease. Atherosclerosis 2005, 183:1-16.
32. Rossouw J.E., Prentice R.L., Manson J.E., Wu L., Barad D., Barnabei V.M., Ko M., LaCroix A.Z., Margolis K.L., Stefanick M.L. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007, 297:1465-1477.
33. Ru L.W., Chen C.C., Liu S., Safe S. 17beta-estradiol (E2) induces cdc25A gene expression in breast cancer cells by genomic and non-genomic pathways. J. Cell Biochem. 2006, 99:209-220.
34. Sander E.E., ten Klooster J.P., van Delft S., van der Kammen R.A., Collard J.G. Rac downregulates Rho activity: reciprocal balance between both Gtpases determines cellular morphology and migratory behavior. J. Cell Biol. 1999, 147:1009-1022.
35. Schiff R., Osborne C.K. Endocrinology and hormone therapy in breast cancer: new insight into estrogen receptor-alpha function and its implication for endocrine therapy resistance in breast cancer. Breast Cancer Res. 2005, 7:205-211.
36. Shimokawa H., Rashid M. Development of Rho-kinase inhibitors for cardiovascular medicine. Trends Pharmacol. Sci. 2007, 28:296-302.
37. Shu F.j., Sidell N., Yang D., Kallen C.B. The tri-nucleotide spacer sequence between estrogen response element half-sites is conserved and modulates ER[alpha]-mediated transcriptional responses. J. Steroid Biochem. Mol. Biol. 2010, 120:172-179.
38. Simoncini T., Scorticati C., Mannella P., Fadiel A., Giretti M.S., Fu X.D., Baldacci C., Garibaldi S., Caruso A., Fornari L., Naftolin F., Genazzani A.R. Estrogen receptor {alpha} interacts with G{alpha}13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho Kinase/Moesin pathway. Mol. Endocrinol. 2006, 20:1756-1771.
39. Sinnett-Smith J., Lunn J.A., Leopoldt D., Rozengurt E. Y-27632, an inhibitor of Rho-associated kinases, prevents tyrosine phosphorylation of focal adhesion kinase and paxillin induced by bombesin: dissociation from tyrosine phosphorylation of p130cas. Exp. Cell Res. 2001, 266:292-302.
40. Sobrino A., Mata M., Laguna-Fernandez A., Novella S., Oviedo P.J., Garcia-Perez M.A., Tarin J.J., Cano A., Hermenegildo C. Estradiol stimulates vasodilatory and metabolic pathways in cultured human endothelial cells. PLoS ONE 2009, 4:e8242.
41. Sobrino A., Oviedo P.J., Novella S., Laguna-Fernandez A., Bueno C., Garcia-Perez M.A., Tarin J.J., Cano A., Hermenegildo C. Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor α. J. Mol. Endocrinol. 2010, 44:237-246.
42. Spyridopoulos I., Andres V. Control of vascular smooth muscle and endothelial cell proliferation and its implication in cardiovascular disease. Front. Biosci. 1998, 3:d269-d287.
43. Spyridopoulos I., Sullivan A.B., Kearney M., Isner J.M., Losordo D.W. Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor. Circulation 1997, 95:1505-1514.
44. Straub R.H. The complex role of estrogens in inflammation. Endocr. Rev. 2007, 28:521-574.
45. Venkov C.D., Rankin A.B., Vaughan D.E. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation 1996, 94:727-733.